当前位置: X-MOL 学术Helicobacter › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice
Helicobacter ( IF 4.4 ) Pub Date : 2021-04-12 , DOI: 10.1111/hel.12807
Wenwei Xie 1 , Wenfeng Zhao 2 , Ziling Zou 1 , Lingyi Kong 1 , Lei Yang 1
Affiliation  

As the resistance of Helicobacter pylori to traditional triple therapy is gradually revealed, an increasing number of people are focusing on vaccine treatments for Hpylori infection. Epitope vaccines are a promising strategy for the treatment of Hpylori infection, and multivalent vaccines will be more effective than monovalent vaccines.

中文翻译:

基于 UreB、HpaA、CAT 和 LTB 的口服多价表位疫苗,用于预防和治疗 C57BL/6 小鼠的幽门螺杆菌感染

由于电阻幽门螺杆菌传统的三联疗法正逐步显现,越来越多的人正专注于疫苗治疗^ h。 幽门螺杆菌感染。表位疫苗是用于治疗一个很有前途的战略^ h。 pylori感染,多价疫苗会比单价疫苗更有效。
更新日期:2021-05-13
down
wechat
bug